Gene expression profiling and racial disparities in outcomes after heart transplantation.

[1]  A. Loupy,et al.  Distinct Patterns of Gene Expression Identified Longitudinally and within AlloMap Score Ranges are Associated with Clinical Outcomes , 2019, The Journal of Heart and Lung Transplantation.

[2]  K. Khush,et al.  Transplant phenomapping: A move toward personalized immunosuppression. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  W. Book,et al.  Racial differences in the development of de-novo donor-specific antibodies and treated antibody-mediated rejection after heart transplantation. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[4]  S. Kaufmann,et al.  The Salmonella Effector SteD Mediates MARCH8-Dependent Ubiquitination of MHC II Molecules and Inhibits T Cell Activation , 2016, Cell host & microbe.

[5]  J. Butler,et al.  Race and ethnic differences in the epidemiology and risk factors for graft failure after heart transplantation. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  G. Ewald,et al.  Gene Expression Profiling to Study Racial Differences after Heart Transplantation , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[7]  J. Butler,et al.  Influence of race/ethnic differences in pre-transplantation panel reactive antibody on outcomes in heart transplant recipients. , 2013, Journal of the American College of Cardiology.

[8]  Eric S. Weiss,et al.  Adult-derived Index for Mortality Prediction After Cardiac Transplantation (IMPACT) risk score predicts short-term mortality after pediatric heart transplantation. , 2012, The Annals of thoracic surgery.

[9]  D. Bernstein,et al.  Gene Polymorphisms Impact the Risk of Rejection With Hemodynamic Compromise: A Multicenter Study , 2011, Transplantation.

[10]  M. Hlatky,et al.  Persistent Racial Disparities in Survival After Heart Transplantation , 2011, Circulation.

[11]  N. Banner,et al.  De Novo Donor HLA‐Specific Antibodies after Heart Transplantation Are an Independent Predictor of Poor Patient Survival , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  Ashish S Shah,et al.  The impact of race on survival after heart transplantation: an analysis of more than 20,000 patients. , 2010, The Annals of thoracic surgery.

[13]  James Yee,et al.  Gene-expression profiling for rejection surveillance after cardiac transplantation. , 2010, The New England journal of medicine.

[14]  K. Gauvreau,et al.  Socioeconomic position, ethnicity, and outcomes in heart transplant recipients. , 2010, The American journal of cardiology.

[15]  J. Fishman,et al.  Disparities in Solid Organ Transplantation for Ethnic Minorities: Facts and Solutions , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  T. Klingler,et al.  Noninvasive Discrimination of Rejection in Cardiac Allograft Recipients Using Gene Expression Profiling , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[17]  Patrick J Heagerty,et al.  Directly parameterized regression conditioning on being alive: analysis of longitudinal data truncated by deaths. , 2005, Biostatistics.

[18]  M. Flattery,et al.  To induce or not to induce: do patients at greatest risk for fatal rejection benefit from cytolytic induction therapy? , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[19]  K. Johansen,et al.  Influence of race on kidney transplant outcomes within and outside the Department of Veterans Affairs. , 2004, Journal of the American Society of Nephrology : JASN.

[20]  A. Thomson,et al.  Flt-3 ligand increases microchimerism but can prevent the therapeutic effect of donor bone marrow in transiently immunosuppressed cardiac allograft recipients. , 1998, Journal of immunology.

[21]  P. Grambsch,et al.  Proportional hazards tests and diagnostics based on weighted residuals , 1994 .